Welcome to K2 Medical Research, a privately-owned clinical research facility in the greater Orlando area. We specialize in conducting multiphasic clinical trials that promote the development of innovative and effective medical treatments while maintaining the safety and privacy of our participants. Here at K2, we are committed to fighting the diseases that plague our loved ones and ourselves. By harnessing the power of advanced clinical research and connecting our patients with the treatments of tomorrow, we can improve the health of our local communities, and by extent, the population of our world.
Dr. Elizabeth (“Beth”) Phillips joins the K2 medical team as a principal investigator with over 25 years of clinical expertise. Board certified in Emergency Medicine, Dr. Phillips’ experience encompasses all levels of emergency departments; in addition to managing emergent care in all areas of medicine, she has served administratively as departmental medical director, and has held faculty appointments as assistant professor and clinical instructor.
Clinical Research as a Care Option (CRAACO) is a concept that is revolutionizing health care as we know it. Considering the use of clinical trials as a tool to supplement and/or replace conventional healthcare is a radical notion, but one that stands to benefit patients, physicians, and the research community as a whole. Some of these benefits include faster drug development, and for patients, a more cost-effective approach with better treatment outcomes. Here at K2 Medical Research, we are fully onboard and are collaborating with local practices to help make this innovative idea a reality for our patients. While traditional healthcare presents many well-known challenges to patients seeking treatment, participating in a clinical research trial offers many practical solutions. By participating in a research study with K2, participants can expect to:
Technology is ever-changing and constantly evolving. If you are in search of professionals who will attend to your needs, you can’t go wrong with K2 Medical. Contact our clinic at your earliest convenience to enroll in a clinical trial.
Studies range from genetic and molecular studies of the mechanisms of cardiovascular disease to studies of vascular properties, lifestyle interventions, and responsiveness to preventive pharmacotherapy.
In the United States, the most common endocrine disease is diabetes. There are many others such as Addison’s Disease, Cushing’s Syndrome, Graves’ Disease and Hashimoto’s Thyroiditis to consider clinical trial participation.
Autoimmune rheumatic diseases (ARDs) are a diverse group of conditions that primarily affect the joints, bones, muscle, and connective tissue such as Rheumatoid Arthritis (RA).
Digestive diseases research for disorders of the digestive tract, which is sometimes called the gastrointestinal (GI) tract such as Gastroesophageal Reflux Disease (GERD), Crohn's Disease Ulcerative Colitis (UC). Irritable Bowel Syndrome (IBS) and Diverticulitis.
Innovative translational research uses biomarkers to accelerate or aid in diagnosis or monitoring and provide insight into “personalized” medicine. A biomarker is a quantifiable biological parameter (such as blood pressure, heart rate, blood and genetic test, and x-rays) that are measured and evaluated over time as an indicator of normal biological, pathogenic, or pharmacologic responses to a therapeutic intervention.
Brandon Lenox, DO is a board-certified anesthesiologist and epidemiologist with a long and distinguished career in medicine. As Chief Medical Officer of K2 Medical Research, Dr. Lenox provides the K2 team with over 20 years’ experience in clinical trials, medical research, and clinical practice. After earning his graduate degree in public health, he went on to graduate from Nova Southeastern University College of Osteopathic Medicine with highest honors then completed his residency training at Johns Hopkins University School of Medicine.